Study of Cyclosporine in the Treatment of Dry Eye Syndrome (ST-603-007)
NCT00548301 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2011-07-01
Summary
The purpose of this phase 3 study is to determine the safety and efficacy of cyclosporine in the treatment of dry eye syndrome.
Conditions
- Dry Eye Syndromes
Interventions
- DRUG
-
cyclosporine
Sponsors & Collaborators
-
Sirion Therapeutics, Inc.
lead INDUSTRY
Principal Investigators
-
Roger Vogel, MD · Sirion Therapeutics
Study Design
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
Countries
- United States
Study Locations
More Related Trials
-
Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye
NCT01488396 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of 0.05% Cyclosporine A Eye Drops Combined With Absorbable Tear Duct Plugs in the Treatment of Dry Eye in Sjögren's Syndrom
NCT07171710 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Efficacy of Topical Cyclosporine Versus Tears for Improving Visual Outcomes Following Multifocal IOL Implantation
NCT00349583 ·Status: COMPLETED ·Phase: PHASE4
-
Cyclosporine 0.05% Eye Drops for Vernal Keratoconjunctivitis Trial
NCT05353101 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease
NCT04139122 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome
NCT03865888 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia
NCT00383396 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 3 Study of OTX-101 in the Treatment of Keratoconjunctivitis Sicca
NCT02688556 ·Status: COMPLETED ·Phase: PHASE3
-
NOVA22007 0.05% and 0.1% Cyclosporine Versus Vehicle for the Treatment of Dry Eye
NCT00739349 ·Status: COMPLETED ·Phase: PHASE2
-
Tear Film Stability and Improvement of Asthenopia: Efficacy Observation of 0.05% Cyclosporine in Dry Eye Patients With Short BUT
NCT06981104 ·Status: COMPLETED ·Phase: NA
-
Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye Disease
NCT02004067 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Cyclosporine Ophthalmic Emulsion in the Treatment of Dry Eye Syndrome in Contact Lens Wearers
NCT00335114 ·Status: COMPLETED ·Phase: NA
-
[KSR-001-P02] Phase 2b/3 Study, Evaluate the Efficacy and Safety of KSR-001 in Patients With Dry Eye Syndrome
NCT05017844 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy
NCT02121847 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease
NCT06766357 ·Status: RECRUITING ·Phase: PHASE3
-
A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye
NCT01558999 ·Status: COMPLETED ·Phase: PHASE2
-
Microvascular and Inflammatory Responses of 0.05 Cyclosporine Eye Drop (II) in Treatment of Dry Eye
NCT05131152 ·Status: UNKNOWN ·Phase: NA
-
Study of Tisporin Eye Drops Group and Restasis Eye Drops Group After Treatment, Each Treatment Group Comparisons for Evaluation of Efficacy and Safety in Moderate to Severe Dry Eye Disease
NCT02229955 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Evaluate the Corneal Endothelial Health of DED Subjects Treated With Cyclosporine
NCT06329661 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Two Formulations of Cyclosporine Ophthalmic Emulsion in Healthy Volunteers and in Patients With Dry Eye
NCT01319773 ·Status: COMPLETED ·Phase: PHASE1
-
A Prospective, Randomized, Placebo and Active Comparator Controlled Study of CP-690,550 in Subjects With Dry Eye.
NCT00784719 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Evaluating the Efficacy and Safety of TJO-087 in Moderate to Severe Dry Eye Disease Patients
NCT05245604 ·Status: UNKNOWN ·Phase: PHASE3
-
A Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears: the FOCUS Study
NCT07234318 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Study to Investigate the Efficacy and Safety of SJP002 Ophthalmic Solution in Patients With Dry Eye Syndrome.
NCT03723811 ·Status: COMPLETED ·Phase: PHASE2
-
Tear Film Markers in Dry Eye Syndrome
NCT04515329 ·Status: WITHDRAWN ·Phase: PHASE4